BioCentury
ARTICLE | Financial News

Athersys completes follow-on

January 27, 2017 9:04 PM UTC

On Jan. 27, regenerative medicine company Athersys Inc. (NASDAQ:ATHX) raised $20 million through the sale of 19.8 million shares at $1.01 in a follow-on underwritten by William Blair and Needham....

BCIQ Company Profiles

Athersys Inc.